Crossmark

The Development of Signs of Alzheimer’s Disease in OXYS Rats Is Accompanied by a Decrease in the Expression of Cerebral Dopamine Neurotrophic Factor (CDNF) and Is Not Compensated by Its Overexpression

Crossref DOI link: https://doi.org/10.1134/S1819712424700351

Published Online: 2025-03-18

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kaminskaya, Ya. P.

Ilchibaeva, T. V.

Kozlova, T. A.

Kolosova, N. G.

Naumenko, V. S.

Tsybko, A. S.
License Information

Text and Data Mining valid from 2024-12-01

Version of Record valid from 2024-12-01
More Information

Article History

Received: 30 June 2024

Revised: 14 July 2024

Accepted: 18 July 2024

First Online: 18 March 2025

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

: Ethical approval. All experimental procedures were carried out in accordance with international guidelines for the care of animals (Guide for the Care and Use of Laboratory Animals, the Eighth Edition, Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council © 2020 National Academy of Sciences (United States)) and approved by the Ethics Committee of the ICG SB RAS.Informed consent. This article does not contain any studies involving human subjects.

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below